Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03523247 · ClinicalTrials.gov registry record · NA
A Whole Food Plant Diet and Its Lipidemic Effects on Primary Prevention in a Free-range Population
A NA study, sponsored by Lancaster General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03523247 is a NA study that has completed, run by Lancaster General Hospital. The registered enrollment target is 50 participants.
The verdict
NCT03523247, a NA study, has completed, sponsored by Lancaster General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study seeks to determine the effects of a whole-food, plant-based diet on lipid, metabolic, and inflammatory biomarkers. Eligible participants will have had either an LDL-C \>100 mg/dL or non-HDL-C \>130 mg/dL without a current diagnosis of coronary heart disease and are willing to adhere to a whole food plant based diet for at least 8 weeks. Participants enrolled in the study will provide fasting blood work, complete a baseline quality of life survey, and receive education on a whole-food, plant-based diet at a local Lancaster County grocery store during their first study visit. Throughout the study, patients will have access to dietary counseling which will be provided by a certified nutritionist and will be asked to record and submit daily food diaries. Study participants will be asked to adhere to a whole food plant based diet for a total of 8 weeks. Prior to the final study visit, participants will be asked to obtain follow-up fasting bloodwork around 7 weeks post start of whole food plant based diet. The results, along with a follow-up quality of life survey, and an opportunity to discuss the bloodwork with a doctor will be held at the local grocery story 8 weeks after the first study visit.
Interventions
- BEHAVIORAL whole food, plant based diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03523247
The ClinicalTrials.gov registry entry for NCT03523247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lancaster General Hospital, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which whole food, plant based diet is the first listed.
NCT03523247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03523247 about?
NCT03523247 is a clinical study titled "A Whole Food Plant Diet and Its Lipidemic Effects on Primary Prevention in a Free-range Population". This study seeks to determine the effects of a whole-food, plant-based diet on lipid, metabolic, and inflammatory biomarkers. Eligible participants will have had either an LDL-C \>100 mg/dL or non-HDL-C \>130 mg/dL without a current diagnosis of coronary heart disease and are willing to adhere to a ...
What is the current status of trial NCT03523247?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-07-18. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03523247?
The interventions under investigation include: whole food, plant based diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03523247?
This trial is sponsored by Lancaster General Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.